Analysis of the contemporary use of high-dose chemotherapy (HDCT) in germ cell tumors (GCT) in Europe: Early findings of an ongoing EBMT-sponsored study

被引：0
|
作者：
Necchi, Andrea
Badoglio, Manuela
Miceli, Rosalba
Bourhis, Jean-Henri
Laszlo, Daniele
Nicolas-Virelizter, Emmanuelle
Wuchter, Patrick
Dreger, Peter
Kruger, William Hermann
Unal, Ali
Campos, Antonio
Montoro, Juan
Raggi, Daniele
Giannatempo, Patrizia
Gianni, Alessandro M.
Pedrazzoli, Paolo
Lanza, Francesco
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
[2] EBMT Study Off, Paris, France
[3] Inst Gustave Roussy, Villejuif, France
[4] European Inst Oncol, Milan, Italy
[5] Ctr Leon Berard, F-69373 Lyon, France
[6] Univ Heidelberg Hosp, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[7] Ernst Moritz Arndt Univ Greifswald, Greifswald, Germany
[8] Erciyes Univ, Kayseri, Turkey
[9] Portuguese Inst Oncol, Oporto, Portugal
[10] Univ Milan, Milan, Italy
[11] IRCCS San Matteo Univ Hosp Fdn, Med Oncol, Pavia, Italy
[12] Ist Ospitalieri Cremona, Cremona, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15536
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15536
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of response to induction chemotherapy in patients with germ cell tumors (GCT) receiving salvage high-dose chemotherapy (HDCT): an EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study
    Necchi, A.
    Miceli, R.
    Bregni, M.
    Berger, L. A.
    Oechsle, K.
    Schumacher, K.
    Bourhis, J. H.
    Laszlo, D.
    Flechon, A.
    Arpaci, F.
    Secondino, S.
    Raggi, D.
    Dreger, P.
    Krueger, W.
    Ringhoffer, M.
    Unal, A.
    Nagler, A.
    Campos
    Wahlin
    Donnini, I.
    Badoglio, M.
    Martino, M.
    Pedrazzoli, P.
    Lanza, F.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S53 - S53
  • [2] Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
    Beyer, J
    Kramar, A
    Mandanas, R
    Linkesch, W
    Greinix, A
    Droz, JP
    Pico, JL
    Diehl, A
    Bokemeyer, C
    Schmoll, HJ
    Nichols, CR
    Einhorn, LH
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 22 : S10 - S10
  • [3] Impact of prior paclitaxel-based chemotherapy on the outcome of salvage high-dose chemotherapy (HDCT) for relapsed germ-cell tumors (GCT): EBMT Solid Tumors Working Party (STWP)-sponsored retrospective study
    Necchi, A.
    Miceli, R.
    Bregni, M.
    Berger, L. A.
    Oechsle, K.
    Schumacher, K.
    Apperley, J.
    Bourhis, J. H.
    Laszlo, D.
    Flechon, A.
    Arpaci, F.
    Secondino, S.
    Dreger, P.
    Crysandt, M.
    Plueger, K. H.
    Worel, N.
    Krueger, W.
    Ringhoffer, M.
    Unal, A.
    Nagler, A.
    Michieli, M.
    Campos, A.
    Wahlin, A.
    Sucak, G.
    Schots, R.
    Donnini, I.
    Raggi, D.
    Giannatempo, P.
    Ifrah, N.
    Badoglio, M.
    Martino, M.
    Pedrazzoli, P.
    Lanza, F.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S55 - S55
  • [4] Outcome in 41 patients with late relapse germ cell tumors (GCT) treated with high-dose chemotherapy (HDCT)
    Lorch, A.
    Rick, O.
    Hartmann, J. T.
    Metzner, B.
    Glasmacher, A.
    Berdel, W.
    Schirren, R.
    Bokemeyer, C.
    Beyer, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Significance of high-dose chemotherapy (HDCT) for male germ cell tumors
    Lorch, A.
    Beyer, J.
    Bokemeyer, C.
    ONKOLOGE, 2013, 19 (07): : 568 - 572
  • [6] Multicenter analysis of high-dose chemotherapy (HDCT) regimens for recurrent germ cell tumors (GCTs).
    Zugman, Miguel
    Shodiya, Michael Olufemi
    Maldonado, Edward
    Othman, Tamer
    Ebrahimi, Hedyeh
    Barragan-Carrillo, Regina
    Li, Xiaochen
    Rock, Adam
    Tripathi, Abhishek
    Pal, Sumanta Kumar
    Dorff, Tanya B.
    Zhumkhawala, Ali
    Hoeg, Rasmus Tetens
    Oliai, Caspian
    Mei, Matthew Genyeh
    Chehrazi-Raffle, Alex
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [7] Stellenwert der Hochdosischemotherapie (HDCT) beim männlichen KeimzelltumorSignificance of high-dose chemotherapy (HDCT) for male germ cell tumors
    A. Lorch
    J. Beyer
    C. Bokemeyer
    Der Onkologe, 2013, 19 (7): : 568 - 572
  • [8] HIGH-DOSE CHEMOTHERAPY (HDCT) AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN GERM CELL TUMORS: THE GITMO/IGG NETWORK
    Rosti, G.
    De Giorgi, U.
    Pedrazzoli, P.
    Salvioni, R.
    ANNALS OF ONCOLOGY, 2009, 20
  • [9] Multicenter analysis of high-dose chemotherapy (HDCT) regimens for the treatment of patients (pts) with recurrent germ cell tumors (GCTs).
    Chehrazi-Raffle, Alex
    Shodiya, Michael Olufemi
    Maldonado, Edward
    Othman, Tamer
    Ebrahimi, Hedyeh
    Carrillo, Regina Barragan
    Li, Xiaochen
    Rock, Adam
    Tripathi, Abhishek
    Pal, Sumanta Kumar
    Dorff, Tanya B.
    Zhumkhawala, Ali
    Hoeg, Rasmus
    Oliai, Caspian
    Olin, Rebecca L.
    Mei, Matthew Genyeh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Has toxicity in young patients with Germ Cell Tumor (GCT) treated with High-Dose Chemotherapy (HDCT) any impact on weight?
    Giannotti, F
    Civinelli, MC
    Martelli, S
    Amati, P
    Peccenini, R
    Zambianchi, H
    Papiani, G
    De Giorgi, L
    Cavallaro, M
    Rosti, G
    Marangolo, M
    BONE MARROW TRANSPLANTATION, 2001, 27 : S389 - S389
12345